Tracking of mesenchymal stem cells labeled with gadolinium diethylenetriamine pentaacetic acid by 7T magnetic resonance imaging in a model of cerebral ischemia

25Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

0.05). In the in vitro T1weighted MRI and in the rat brain, a high signal intensity was observed in the labeled MSCs. The T1weighted imaging of the labeled cells revealed a significantly higher signal intensity compared with that of the unlabeled cells (P<0.05) and the T1 values were significantly lower. The function of the labeled MSCs demonstrated no change following GdDTPA labeling, with no evident adverse effect on cell viability or proliferation. Therefore, a change in MR signal intensity was detected in vitro and in vivo, suggesting GdDTPA can be used to label MSCs for MRI tracking.

Cite

CITATION STYLE

APA

Geng, K., Yang, Z. X., Huang, D., Yi, M., Jia, Y., Yan, G., … Wu, R. (2015). Tracking of mesenchymal stem cells labeled with gadolinium diethylenetriamine pentaacetic acid by 7T magnetic resonance imaging in a model of cerebral ischemia. Molecular Medicine Reports, 11(2), 954–960. https://doi.org/10.3892/mmr.2014.2805

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free